These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21150778)

  • 21. Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study.
    Xie Y; Mintz GS; Yang J; Doi H; Iñiguez A; Dangas GD; Serruys PW; McPherson JA; Wennerblom B; Xu K; Weisz G; Stone GW; Maehara A
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):397-405. PubMed ID: 24631511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
    Lansky AJ; Ng VG; Maehara A; Weisz G; Lerman A; Mintz GS; De Bruyne B; Farhat N; Niess G; Jankovic I; Lazar D; Xu K; Fahy M; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S62-72. PubMed ID: 22421232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome.
    Kurose S; Iwasaka J; Tsutsumi H; Yamanaka Y; Shinno H; Fukushima Y; Higurashi K; Imai M; Masuda I; Takeda S; Kawai C; Kimura Y
    Heart Vessels; 2016 Jun; 31(6):846-54. PubMed ID: 25896129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
    Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
    Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
    Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
    Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography.
    Kang J; Park KW; Lee MS; Zheng C; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):130. PubMed ID: 29954346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.
    Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J
    Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention.
    McPherson JA; Maehara A; Weisz G; Mintz GS; Cristea E; Mehran R; Foster M; Verheye S; Rabbani L; Xu K; Fahy M; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S76-85. PubMed ID: 22421234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.
    Wan K; Zhao J; Huang H; Zhang Q; Chen X; Zeng Z; Zhang L; Chen Y
    PLoS One; 2015; 10(4):e0123521. PubMed ID: 25880982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.
    Matsumoto I; Miyake Y; Mizukawa M; Takagi Y
    Circ J; 2011; 75(4):905-10. PubMed ID: 21325724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A higher non-HDL-C/HDL-C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Liu J; Zhao L; Zhang Y; Wang L; Feng Q; Cui J; Zhang W; Zheng J; Wang D; Zhao F; He J; Chen Y
    Clin Cardiol; 2024 Feb; 47(2):e24243. PubMed ID: 38402557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-density lipoprotein cholesterol target goal attainment rate and related factors in patients with acute coronary syndrome after percutaneous coronary intervention].
    Zhang B; Dong X; Zhang Y; Huang R; Yin D; Zheng Z; Liu Y; Zhu H; Zhou X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):290-4. PubMed ID: 24924454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).
    Zhao XQ; Krasuski RA; Baer J; Whitney EJ; Neradilek B; Chait A; Marcovina S; Albers JJ; Brown BG
    Am J Cardiol; 2009 Dec; 104(11):1457-64. PubMed ID: 19932775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.